Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.

Lusky M, Christ M, Rittner K, Dieterle A, Dreyer D, Mourot B, Schultz H, Stoeckel F, Pavirani A, Mehtali M.

J Virol. 1998 Mar;72(3):2022-32.

2.

Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.

Gorziglia MI, Lapcevich C, Roy S, Kang Q, Kadan M, Wu V, Pechan P, Kaleko M.

J Virol. 1999 Jul;73(7):6048-55.

3.

Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.

Andrews JL, Kadan MJ, Gorziglia MI, Kaleko M, Connelly S.

Mol Ther. 2001 Mar;3(3):329-36.

4.
6.
7.

Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.

Dedieu JF, Vigne E, Torrent C, Jullien C, Mahfouz I, Caillaud JM, Aubailly N, Orsini C, Guillaume JM, Opolon P, Delaere P, Perricaudet M, Yeh P.

J Virol. 1997 Jun;71(6):4626-37.

8.

Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.

Christ M, Louis B, Stoeckel F, Dieterle A, Grave L, Dreyer D, Kintz J, Ali Hadji D, Lusky M, Mehtali M.

Hum Gene Ther. 2000 Feb 10;11(3):415-27.

PMID:
10697116
9.
10.

Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.

Raper SE, Haskal ZJ, Ye X, Pugh C, Furth EE, Gao GP, Wilson JM.

Hum Gene Ther. 1998 Mar 20;9(5):671-9.

PMID:
9551615
11.
12.
14.
15.

A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.

Zhou H, Zhao T, Pastore L, Nageh M, Zheng W, Rao XM, Beaudet AL.

Mol Ther. 2001 Apr;3(4):613-22.

16.

An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.

Catalucci D, Sporeno E, Cirillo A, Ciliberto G, Nicosia A, Colloca S.

J Virol. 2005 May;79(10):6400-9.

17.

Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.

Engelhardt JF, Litzky L, Wilson JM.

Hum Gene Ther. 1994 Oct;5(10):1217-29.

PMID:
7849095
19.

Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity.

Osada T, Yang XY, Hartman ZC, Glass O, Hodges BL, Niedzwiecki D, Morse MA, Lyerly HK, Amalfitano A, Clay TM.

Cancer Gene Ther. 2009 Sep;16(9):673-82. doi: 10.1038/cgt.2009.17. Epub 2009 Feb 20.

20.

[Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes].

Shimizu K, Sakurai F, Tachibana M, Mizuguchi H.

Yakugaku Zasshi. 2012;132(12):1407-12. Review. Japanese.

Supplemental Content

Support Center